US EditionPublished • loading... • Updated
Analog Pharma Canada Launches First Product On Cdn. Market - Canadian Manufacturing
Summary by Canadian Manufacturing
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Analog Pharma Canada Launches First Product On Cdn. Market - Canadian Manufacturing
Éric Gervais, President, DPG, Dany Hallé, Vice President, Commercial Affairs, DPG, Frank Olivier Labelle, Associate Director, Analog Pharma Canada (CNW Group/Analog Pharma Canada) BLAINVILLE — Analog Pharma Canada, a pharmaceutical company specializing in generics for rare and ultra-rare diseases, announces the launch of its first product PrALOG-Doxylamine/PyridoxineTM (doxylamine succinate and pyridoxine hydrochloride), intended for use in preg…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
